Elisabetta Fenocchio Selected Research

Complement System Proteins (Complement)

3/2022

Collision of germline POLE and PMS2 variants in a young patient treated with immune checkpoint inhibitors.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Elisabetta Fenocchio Research Topics

Disease

16	Colorectal Neoplasms (Colorectal Cancer) 01/2023 - 10/2019
11	Neoplasms (Cancer) 01/2023 - 01/2018
6	Microsatellite Instability 01/2023 - 01/2021
3	Pancreatic Neoplasms (Pancreatic Cancer) 11/2023 - 10/2016
3	Disease Progression 12/2020 - 01/2020
2	Stomach Neoplasms (Stomach Cancer) 06/2023 - 01/2022
2	Inflammation (Inflammations) 06/2022 - 01/2021
2	Carcinoma (Carcinomatosis) 03/2022 - 01/2018
2	Neoplasm Metastasis (Metastasis) 01/2022 - 01/2022
2	Gastrointestinal Neoplasms (Gastrointestinal Cancer) 01/2022 - 01/2018
2	Cholangiocarcinoma 01/2021 - 11/2020
1	Adenocarcinoma 11/2023
1	Cardiotoxicity 01/2023
1	Biliary Tract Neoplasms (Biliary Tract Cancer) 12/2022
1	Ascites 01/2022
1	Frailty 01/2022
1	Melanoma (Melanoma, Malignant) 07/2021
1	Adenocarcinoma of Lung 07/2021
1	Rectal Neoplasms (Rectal Cancer) 01/2020
1	Hamman-Rich Syndrome (Hamman Rich Syndrome) 10/2016
1	Pneumonia (Pneumonitis) 10/2016
1	Respiratory Insufficiency (Respiratory Failure) 10/2016
1	Fibrosis (Cirrhosis) 10/2016

Drug/Important Bio-Agent (IBA)

7	Immune Checkpoint InhibitorsIBA 01/2023 - 01/2021
4	Biomarkers (Surrogate Marker)IBA 01/2023 - 01/2021
3	Oxaliplatin (Eloxatin)FDA LinkGeneric 01/2022 - 01/2018
2	Proteins (Proteins, Gene)FDA Link 06/2023 - 01/2023
2	RNA (Ribonucleic Acid)IBA 01/2023 - 07/2021
2	trifluridine tipiracil drug combinationIBA 01/2023 - 01/2021
2	ErbB Receptors (EGF Receptor)IBA 01/2022 - 10/2019
2	Lapatinib (GW572016)FDA Link 12/2020 - 01/2020
2	pertuzumabIBA 12/2020 - 01/2020
2	Trastuzumab (Herceptin)FDA Link 12/2020 - 01/2020
2	Gemcitabine FDA Link 01/2018 - 10/2016
1	Phosphopyruvate Hydratase (Enolase)IBA 11/2023
1	AutoantibodiesIBA 11/2023
1	Carrier Proteins (Binding Protein)IBA 11/2023
1	ElementsIBA 11/2023
1	RadiopharmaceuticalsIBA 06/2023
1	Codon (Codons)IBA 01/2023
1	Calcibiotic Root Canal SealerIBA 01/2023
1	Complement System Proteins (Complement)IBA 03/2022
1	Monoclonal AntibodiesIBA 01/2022
1	Panitumumab (Vectibix)FDA Link 01/2022
1	Circulating Tumor DNAIBA 01/2022
1	CTLA-4 AntigenIBA 01/2022
1	Vitamin D FDA LinkGeneric 01/2021
1	Metformin (Glucophage)FDA LinkGeneric 01/2021
1	regorafenibIBA 01/2021
1	Ado-Trastuzumab EmtansineIBA 01/2020
1	Irinotecan (Camptosar)FDA LinkGeneric 01/2020
1	Leucovorin (Folinic Acid)FDA Link 01/2020
1	Bevacizumab (Avastin)FDA Link 01/2020
1	Fluorouracil (Carac)FDA LinkGeneric 01/2020
1	Antineoplastic Agents (Antineoplastics)IBA 01/2018
1	SteroidsIBA 10/2016
1	Imatinib Mesylate (Gleevec)FDA Link 10/2016

Therapy/Procedure

10	Therapeutics 11/2023 - 10/2016
10	Drug Therapy (Chemotherapy) 01/2023 - 10/2016
1	Immunotherapy 03/2022
1	Palliative Care (Palliative Therapy) 01/2020
1	Immunomodulation 01/2018